Met degradation: More than one stone to shoot a receptor down

FASEB Journal

Volumn 26, Issue 4, 2012, Pages 1387-1399

  Lefebvre, Jonathan ^a   Ancot, Frédéric ^a   Leroy, Catherine ^a   Muharram, Ghaffar ^a   Lemière, Arnaud ^a   Tulasne, David ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

secretase; Caspase; Cleavages; Hepatocyte growth factor; Metalloprotease; Receptor tyrosine kinase

Indexed keywords

CHAPERONIN; DECORIN; INTERNALIN B; LIGAND; MEMBRANE PROTEIN; PROTEIN LRIG1; PROTEIN VARIANT; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENESIS; CELL COMPARTMENTALIZATION; EMBRYO DEVELOPMENT; ENDOCYTOSIS; GENE OVEREXPRESSION; INTERNALIZATION; LYSOSOME; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HEPATOCYTE GROWTH FACTOR; HUMANS; LIGANDS; LYSOSOMES; NEOPLASMS; PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

EID: 84860906789     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-197723     Document Type: Review

References (84)

1. Park, M., Dean, M., Kaul, K., Braun, M. J., Gonda, M. A., and Vande Woude, G. (1987) Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. U. S. A. 84, 6379-6383 (Pubitemid 18002806)
2. Birchmeier, C., Birchmeier, W., Gherardi, E., and Vande Woude, G. F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell. Biol. 4, 915-925 (Pubitemid 37493640)
3. Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., and Birchmeier, C. (1995) Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376, 768-771
4. Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., and Birchmeier, C. (1995) Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373, 699-702
5. Uehara, Y., Minowa, O., Mori, C., Shlota, K., Kuno, J., Noda, T., and Kitamura, N. (1995) Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373, 702-705
6. Maina, F., Hilton, M. C., Ponzetto, C., Davies, A. M., and Klein, R. (1997) Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes Dev. 11, 3341-3350 (Pubitemid 28023958)
7. Yant, J., Buluwela, L., Niranjan, B., Gusterson, B., and Kamalati, T. (1998) In vivo effects of hepatocyte growth factor/scatter factor on mouse mammary gland development. Exp. Cell Res. 241, 476-481 (Pubitemid 28366573)
8. Kawaida, K., Matsumoto, K., Shimazu, H., and Nakamura, T. (1994) Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc. Natl. Acad. Sci. U. S. A. 91, 4357-4361 (Pubitemid 24143432)
9. Borowiak, M., Garratt, A. N., Wustefeld, T., Strehle, M., Trautwein, C., and Birchmeier, C. (2004) Met provides essential signals for liver regeneration. Proc. Natl. Acad. Sci. U. S. A. 101, 10608-10613 (Pubitemid 38955789)
10. Naldini, L., Weidner, K. M., Vigna, E., Gaudino, G. K., Bardelli, A., Ponzetto, C., Narsimhan, R. P., Hartmann, G., Zarnegar, R., Michalopoulos, G., Birchmeier, W., and Comoglio, P. M. (1991) Scatter factor and hepatocyte growth factor are undistinguishable ligands for the MET receptor. EMBO J. 10, 2867-2878 (Pubitemid 21905304)
11. Ferracini, R., Longati, P., Naldini, L., Vigna, E., and Comoglio, P. M. (1991) Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase. J. Biol. Chem. 266, 19558-19564 (Pubitemid 21908266)
12. Longati, P., Bardelli, A., Ponzetto, C., Naldini, L., and Comoglio, P. M. (1994) Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 9, 49-57
13. Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graaziani, A., Panayotou, G., and Comoglio, P. M. (1994) A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77, 261-271 (Pubitemid 24138623)
14. Weidner, K. M., Sachs, M., and Birchmeier, W. (1995) Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-offunction mutations of the met receptor in epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 92, 2597-2601
15. Tulasne, D., Paumelle, R., Weidner, K. M., Vandenbunder, B., and Fafeur, V. (1999) The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. Mol. Biol. Cell 10, 551-565 (Pubitemid 29144623)
16. Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G., and Vande Woude, G. F. (1986) Mechanism of met oncogene activation. Cell 45, 895-904 (Pubitemid 16083694)
17. Schmidt, L., Duh, F. M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., Allikmets, R., Chidambaram, A., Bergerheim, U. R., Feltis, J. T., Casadevall, C., Zamarron, A., Bernues, M., Richard, S., Lips, C. J., Walther, M. M., Tsui, L. C., Geil, L., Orcutt, M. L., Stackhouse, T., Lipan, J., Slife, L., Brauch, H., Decker, J, Niehans, G., Hughson, M. D., Moch, H., Storkel, S., Lerman, M. I., Linehan, W. M., Zbar, B. (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16, 68-73 (Pubitemid 27198158)
18. Ponzetto, C., Giordano, S., Peverali, F., Della Valle, G., Abate, M. L., Vaula, G., and Comoglio, P. M. (1991) c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene 6, 553-559 (Pubitemid 21924118)
19. Di Renzo, M. F., Olivero, M., Giacomini, A., Porte, H., Chastre, E., Mirossay, L., Nordlinger, B., Bretti, S., Bottardi, S., and Giordano, S. (1995) Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin. Cancer Res. 1, 147-154
20. Gambarotta, G., Boccaccio, C., Giordano, S., Ando, M., Stella, M. C., and Comoglio, P. M. (1996) Ets up-regulates MET transcription. Oncogene 13, 1911-1917 (Pubitemid 26397450)
21. Ivan, M., Bond, J. A., Prat, M., Comoglio, P. M., and Wynford- Thomas, D. (1997) Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene 14, 2417-2423 (Pubitemid 27268160)
22. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., and Comoglio, P. M. (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347-361 (Pubitemid 38340304)
23. Migliore, C., Petrelli, A., Ghiso, E., Corso, S., Capparuccia, L., Eramo, A., Comoglio, P. M., and Giordano, S. (2008) MicroRNAs impair MET-mediated invasive growth. Cancer Res. 68, 10128-10136
24. Yan, D., Dong Xda, E., Chen, X., Wang, L., Lu, C., Wang, J., Qu, J., and Tu, L. (2009) MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J. Biol. Chem. 284, 29596-29604
25. Jeffers, M., Taylor, G. A., Weidner, K. M., Omura, S., and Vande-Woude, G. F. (1997) Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol. Cell. Biol. 17, 799-808 (Pubitemid 27044379)
26. Madshus, I. H., and Stang, E. (2009) Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking. J. Cell Sci. 122, 3433-3439
27. Abella, J. V., and Park, M. (2009) Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases. Am. J. Physiol. Endocrinol. Metab. 296, E973-E984
28. Peschard, P., Fournier, T. M., Lamorte, L., Naujokas, M. A., Band, H., Langdon, W. Y., and Park, M. (2001) Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol. Cell. 8, 995-1004 (Pubitemid 34031802)
29. Carter, S., Urbe, S., and Clague, M. J. (2004) The met receptor degradation pathway: requirement for Lys48-linked polyubiquitin independent of proteasome activity. J. Biol. Chem. 279, 52835-52839 (Pubitemid 40051783)
30. Abella, J. V., Peschard, P., Naujokas, M. A., Lin, T., Saucier, C., Urbe, S., and Park, M. (2005) Met/hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation. Mol. Cell. Biol. 25, 9632-9645 (Pubitemid 41507861)
31. Traub, L. M. (2009) Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat. Rev. Mol. Cell. Biol. 10, 583-596
32. Motley, A., Bright, N. A., Seaman, M. N., and Robinson, M. S. (2003) Clathrin-mediated endocytosis in AP-2-depleted cells. J. Cell Biol. 162, 909-918 (Pubitemid 37087730)
33. Take, H., Watanabe, S., Takeda, K., Yu, Z. X., Iwata, N., and Kajigaya, S. (2000) Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl. Biochem. Biophys. Res. Commun. 268, 321-328 (Pubitemid 30119620)
34. Petrelli, A., Gilestro, G. F., Lanzardo, S., Comoglio, P. M., Migone, N., and Giordano, S. (2002) The endophilin-CIN85- Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 416, 187-190 (Pubitemid 34246477)
35. Soubeyran, P., Kowanetz, K., Szymkiewicz, I., Langdon, W. Y., and Dikic, I. (2002) Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416, 183-187 (Pubitemid 34246476)
36. Hammond, D. E., Carter, S., McCullough, J., Urbe, S., Vande Woude, G., and Clague, M. J. (2003) Endosomal dynamics of Met determine signaling output. Mol. Biol. Cell 14, 1346-1354 (Pubitemid 36547405)
37. Salcini, A. E., Chen, H., Iannolo, G., De Camilli, P., and Di Fiore, P. P. (1999) Epidermal growth factor pathway substrate 15, Eps15. Int. J. Biochem. Cell Biol. 31, 805-809 (Pubitemid 29354077)
38. De Melker, A. A., van der Horst, G., and Borst, J. (2004) Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment. J. Biol. Chem. 279, 55465-55473 (Pubitemid 40066547)
39. Parachoniak, C. A., and Park, M. (2009) Distinct recruitment of Eps15 via its coiled-coil domain is required for efficient downregulation of the met receptor tyrosine kinase. J. Biol. Chem. 284, 8382-8394
40. Raiborg, C., Bache, K. G., Mehlum, A., Stang, E., and Stenmark, H. (2001) Hrs recruits clathrin to early endosomes. EMBO J. 20, 5008-5021 (Pubitemid 32848652)
41. Gillooly, D. J., Raiborg, C., and Stenmark, H. (2003) Phosphatidylinositol 3-phosphate is found in microdomains of early endosomes. Histochem. Cell Biol. 120, 445-453 (Pubitemid 38058199)
42. Mizuno, E., Kawahata, K., Okamoto, A., Kitamura, N., and Komada, M. (2004) Association with Hrs is required for the early endosomal localization, stability, and function of STAM. J. Biochem. 135, 385-396 (Pubitemid 38506764)
43. Komada, M., and Kitamura, N. (2005) The Hrs/STAM complex in the downregulation of receptor tyrosine kinases. J. Biochem. 137, 1-8
44. Bache, K. G., Brech, A., Mehlum, A., and Stenmark, H. (2003) Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J. Cell Biol. 162, 435-442 (Pubitemid 36988552)
45. Hammond, D. E., Urbe, S., Vande Woude, G. F., and Clague, M. J. (2001) Down-regulation of MET, the receptor for hepatocyte growth factor. Oncogene 20, 2761-2770 (Pubitemid 32549833)
46. Goormachtigh, G., Ji, Z., Le Goff, A., and Fafeur, V. (2011) Degradation of the GAB1 adaptor by the ubiquitin-proteasome pathway hampers HGF/SF-MET signaling. Biochem. Biophys. Res. Commun. 411, 780-785
47. Parachoniak, C. A., Luo, Y., Abella, J. V., Keen, J. H., and Park, M. (2011) GGA3 functions as a switch to promote Met receptor recycling, essential for sustained ERK and cell migration. Dev. Cell. 20, 751-763
48. Kermorgant, S., Zicha, D., and Parker, P. J. (2003) Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met. J. Biol. Chem. 278, 28921-28929 (Pubitemid 36935802)
49. Kermorgant, S., Zicha, D., and Parker, P. J. (2004) PKC controls HGF-dependent c-Met traffic, signalling and cell migration. EMBO J. 23, 3721-3734 (Pubitemid 39389704)
50. Kermorgant, S., and Parker, P. J. (2008) Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J. Cell Biol. 182, 855-863
51. Boccaccio, C., Ando, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini, C., and Comoglio, P. M. (1998) Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391, 285-288 (Pubitemid 28099015)
52. Zhang, Y. W., Wang, L. M., Jove, R., and Vande Woude, G. F. (2002) Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis. Oncogene 21, 217-226 (Pubitemid 34102130)
53. McShane, M. P., and Zerial, M. (2008) Survival of the weakest: signaling aided by endosomes. J. Cell Biol. 182, 823-825
54. Luthi, A. U., and Martin, S. J. (2007) The CASBAH: a searchable database of caspase substrates. Cell Death Differ. 14, 641-650 (Pubitemid 46444502)
55. Ancot, F., Foveau, B., Lefebvre, J., Leroy, C., and Tulasne, D. (2009) Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity. Oncogene 28, 2185-2195
56. Tulasne, D., Deheuninck, J., Lourenco, F. C., Lamballe, F., Ji, Z., Leroy, C., Puchois, E., Moumen, A., Maina, F., Mehlen, P., and Fafeur, V. (2004) Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol. Cell. Biol. 24, 10328-10339 (Pubitemid 39507870)
57. Deheuninck, J., Foveau, B., Goormachtigh, G., Leroy, C., Ji, Z., Tulasne, D., and Fafeur, V. (2008) Caspase cleavage of the MET receptor generates an HGF interfering fragment. Biochem. Biophys. Res. Commun. 367, 573-577
58. Foveau, B., Leroy, C., Ancot, F., Deheuninck, J., Ji, Z., Fafeur, V., and Tulasne, D. (2007) Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor. Cell Death Differ. 14, 752-764 (Pubitemid 46444513)
59. Goldschneider, D., and Mehlen, P. (2010) Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 29, 1865-1882
60. Kopitz, C., Gerg, M., Bandapalli, O. R., Ister, D., Pennington, C. J., Hauser, S., Flechsig, C., Krell, H. W., Antolovic, D., Brew, K., Nagase, H., Stangl, M., von Weyhern, C. W., Brucher, B. L., Brand, K., Coussens, L. M., Edwards, D. R., and Kruger, A. (2007) Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res. 67, 8615-8623 (Pubitemid 47437437)
61. Schelter, F., Kobuch, J., Moss, M. L., Becherer, J. D., Comoglio, P. M., Boccaccio, C., and Kruger, A. (2010) A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor. J. Biol. Chem. 285, 26335-26340
62. Galvani, A. P., Cristiani, C., Carpinelli, P., Landonio, A., and Bertolero, F. (1995) Suramin modulates cellular levels of hepatocyte growth factor receptor by inducing shedding of a soluble form. Biochem. Pharmacol. 50, 959-966
63. Prat, M., Crepaldi, T., Gandino, L., Giordano, S., Longati, P., and Comoglio, P. (1991) C-terminal truncated forms of Met, the hepatocyte growth factor receptor. Mol. Cell. Biol. 11, 5954-5962 (Pubitemid 21895364)
64. Wajih, N., Walter, J., and Sane, D. C. (2002) Vascular origin of a soluble truncated form of the hepatocyte growth factor receptor (c-met). Circ. Res. 90, 46-52 (Pubitemid 34074607)
65. Foveau, B., Ancot, F., Leroy, C., Petrelli, A., Reiss, K., Vingtdeux, V., Giordano, S., Fafeur, V., and Tulasne, D. (2009) Downregulation of the Met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis. Mol. Biol. Cell 20, 2494-2506
66. Trusolino, L., Bertotti, A., and Comoglio, P. M. (2010) MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell. Biol. 11, 834-848
67. Shattuck, D. L., Miller, J. K., Laederich, M., Funes, M., Petersen, H., Carraway, K. L., 3rd, and Sweeney, C. (2007) LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. Mol. Cell. Biol. 27, 1934-1946
68. Goldoni, S., Humphries, A., Nystrom, A., Sattar, S., Owens, R. T., McQuillan, D. J., Ireton, K., and Iozzo, R. V. (2009) Decorin is a novel antagonistic ligand of the Met receptor. J. Cell Biol. 185, 743-754
69. Buraschi, S., Pal, N., Tyler-Rubinstein, N., Owens, R. T., Neill, T., and Iozzo, R. V. (2010) Decorin antagonizes Met receptor activity and down-regulates β-catenin and Myc levels. J. Biol. Chem. 285, 42075-42085
70. Niemann, H. H., Jager, V., Butler, P. J., van den Heuvel, J., Schmidt, S., Ferraris, D., Gherardi, E., and Heinz, D. W. (2007) Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB. Cell 130, 235-246 (Pubitemid 47081132)
71. Shen, Y., Naujokas, M., Park, M., and Ireton, K. (2000) InIBdependent internalization of Listeria is mediated by the Met receptor tyrosine kinase. Cell 103, 501-510
72. Ferraris, D. M., Gherardi, E., Di, Y., Heinz, D. W., and Niemann, H. H. (2010) Ligand-mediated dimerization of the Met receptor tyrosine kinase by the bacterial invasion protein InlB. J. Mol. Biol. 395, 522-532
73. Ireton, K., Payrastre, B., Chap, H., Ogawa, W., Sakaue, H., Kasuga, M., and Cossart, P. (1996) A role for phosphoinositide 3-kinase in bacterial invasion. Science 274, 780-782 (Pubitemid 26398257)
74. Veiga, E., and Cossart, P. (2005) Listeria hijacks the clathrindependent endocytic machinery to invade mammalian cells. Nat. Cell Biol. 7, 894-900 (Pubitemid 41486290)
75. Kong-Beltran, M., Seshagiri, S., Zha, J., Zhu, W., Bhawe, K., Mendoza, N., Holcomb, T., Pujara, K., Stinson, J., Fu, L., Severin, C., Rangell, L., Schwall, R., Amler, L., Wickramasinghe, D., and Yauch, R. (2006) Somatic mutations lead to an oncogenic deletion of met in lung cancer. Cancer Res. 66, 283-289 (Pubitemid 43166034)
76. Ma, P. C., Jagadeeswaran, R., Jagadeesh, S., Tretiakova, M. S., Nallasura, V., Fox, E. A., Hansen, M., Schaefer, E., Naoki, K., Lader, A., Richards, W., Sugarbaker, D., Husain, A. N., Christensen, J. G., and Salgia, R. (2005) Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res. 65, 1479-1488 (Pubitemid 40270177)
77. Onozato, R., Kosaka, T., Kuwano, H., Sekido, Y., Yatabe, Y., and Mitsudomi, T. (2009) Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers. J. Thorac. Oncol. 4, 5-11
78. Mak, H. H., Peschard, P., Lin, T., Naujokas, M. A., Zuo, D., and Park, M. (2007) Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway. Oncogene 26, 7213-7221 (Pubitemid 350085315)
79. Joffre, C., Barrow, R., Menard, L., Calleja, V., Hart, I. R., and Kermorgant, S. (2011) A direct role for Met endocytosis in tumorigenesis. Nat. Cell Biol. 13, 827-837
80. Qin, S., Taglienti, M., Nauli, S. M., Contrino, L., Takakura, A., Zhou, J., and Kreidberg, J. A. (2010) Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease. J. Clin. Invest. 120, 3617-3628
81. Petrelli, A., Circosta, P., Granziero, L., Mazzone, M., Pisacane, A., Fenoglio, S., Comoglio, P. M., and Giordano, S. (2006) Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity. Proc. Natl. Acad. Sci. U. S. A. 103, 5090-5095
82. Pacchiana, G., Chiriaco, C., Stella, M. C., Petronzelli, F., De Santis, R., Galluzzo, M., Carminati, P., Comoglio, P. M., Michieli, P., and Vigna, E. (2010) Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody. J. Biol. Chem. 285, 36149-36157
83. Coleman, D. T., Bigelow, R., and Cardelli, J. A. (2009) Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/ lysosomal degradation. Mol. Cancer Ther. 8, 214-224
84. Uddin, S., Hussain, A. R., Ahmed, M., Bu, R., Ahmed, S. O., Ajarim, D., Al-Dayel, F., Bavi, P., and Al-Kuraya, K. S. (2010) Inhibition of fatty acid synthase suppresses c-Met receptor kinase and induces apoptosis in diffuse large B-cell lymphoma. Mol. Cancer Ther. 9, 1244-1255